Navigation Links
The First Patient Treated Using Celsense MRI Cell Tracking Technology
Date:4/11/2013

Pittsburgh, PA (PRWEB) April 11, 2013

Celsense, Inc. announced today that the first patient to have transplanted cells imaged by magnetic resonance imaging (MRI) using the company’s Cell Sense technology has been treated at the University of Pittsburgh Cancer Institute (UPCI).    The Phase 1 clinical trial was cleared by the US FDA for the purposes of developing information regarding cell migration following administration of live cells.

This application, involving the use of an autologous dendritic cell vaccine to treat colorectal cancer, is the first time the trafficking of a live cell cancer vaccine in patients has been visualized by MRI in the United States. The administration of live cell vaccines is an emerging strategy to treat a variety of cancers.

Investigators believe that the unaided trafficking of dendritic cells to the lymph node is fundamental to the success of this therapeutic strategy. "We are excited that this study is finally moving forward. While this is only the first patient to be imaged in the clinical trial, we expect that data from this study as a whole will lead to improved outcomes for patients receiving live cell vaccines for cancer," said Charlie O'Hanlon, President and CEO of Celsense.

“Where infused therapeutic cells migrate, how many go where, and how long they stay is something about which we have very little data in a clinical setting. To-date there have been few, if any, tools at our disposal to use in obtaining this information in humans,” says cell therapy industry analyst, Lee Buckler, Managing Director of the Cell Therapy Group. “Cell Sense certainly represents one of the first and only cell imaging technologies that has been cleared by a regulatory agency for human use and to that extent it signals a significant step forward
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Finally, the need of nearly every woman wanting to look more beautiful is fulfilled with Crisalix, the first online direct-to-consumer 3D imaging using standard pictures
2. Dr. Ritchie Shoemaker Proudly Announces First Graduate of Shoemaker Protocol Certification Training
3. The First Dedicated Breast Cancer Cell Line Transfection Reagent
4. First Warning Systems, Inc., Appoints Veteran Medical Executive Royea as CEO
5. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
6. First Time in Philadelphia Is a Success for Pittcon 2013 (Summary Report)
7. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
8. Medifirst Solutions, Inc. Announces Further Update To Shareholders
9. BioMed Realty Trust Declares First Quarter 2013 Common Stock Dividend
10. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
11. First-To-File Patent Law Is Now In Effect, But What Does it Mean?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Mo. From cell phones to cars and ... life. Scientists and technology companies constantly are seeking ... for the first time using a water-based solution, ... a long-lasting and more efficient nuclear battery that ... a reliable energy source in automobiles and also ...
(Date:9/16/2014)... BlueInGreen® , a water quality company ... dissolved gases into liquids, announced the addition of ... representative firm to its sales network. H2Flow will ... and wastewater applications in the Canadian provinces of ... 1992 and serves Quebec and Ontario markets for ...
(Date:9/16/2014)... Fresne, President and CEO of Egenix, Inc. is pleased to ... its Scientific Advisory Committee. Dr. Vagner, a graduate ... performed research at Embl (European Molecular Biology Laboratory) Heidelberg, ... of health and medical research. He is a Research Director ... France , and at the Gustave Roussy ...
(Date:9/16/2014)... 16, 2014  The Council for Entrepreneurial Development ... in the country, today released a mid-year update ... It showed that in the first ... startups in the technology, life science, advanced ... from a variety of sources. Significant investment in technology ...
Breaking Biology Technology:BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc. 2New Appointment to the Scientific Advisory Committee at Egenix, Inc. 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4
... Oct. 19 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... global biopharmaceutical company focused on endocrine therapy and ... intended to complete the clinical development of the ... macimorelin (AEZS-130) which could be the first oral ...
... Calif., Oct. 18 /PRNewswire / -- ... of human induced pluripotent stem cells (iPSCs) using a ... and efficiency of reprogramming. The discoveries, which were ... between Fate Therapeutics and The Scripps Research Institute (TSRI), ...
... Oct. 16 Summerhill Biomass Systems is planting the seeds ... named after the Cayuga County community where the technology was ... for grinding up timber, brush, corn stalks and other plant ... James T. McKnight, Summerhill president and co-founder, said he,s eager ...
Cached Biology Technology:AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin (AEZS-130) as First Oral Diagnostic Test for Growth Hormone Deficiency 3Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 2Fate Therapeutics Announces Creation of Small Molecule Platform for Commercial Scale Reprogramming 3Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo 2Summerhill Biomass Systems Unveils Solid Biomass Technology System at Syracuse Expo 3
(Date:9/16/2014)... -- Valencell, Inc., a leader in performance biometric data sensor ... Companies" representing North Carolina,s hottest ... Conference on September 16-17 th at the ... Raleigh, North Carolina . Valencell,s President Dr. ... "Digital Health Spotlight Sector" on how the Company,s internationally ...
(Date:9/16/2014)... , Sept. 16, 2014 As open enrollment ... important decisions about their 2015 benefits. According to ... solutions business of Aon plc (NYSE: ... a more proactive role in managing their health care ... ever for individuals to understand how they can make ...
(Date:9/15/2014)... and gut microbes influence processes from digestion to disease ... most biodiverse terrestrial ecosystems on the planet, more is ... the tropics. Smithsonian scientists and colleagues working on Panama,s ... a single tree were home to more than 400 ... tree species contained more than 7,000 different kinds. , ...
Breaking Biology News(10 mins):Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 2Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 3Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 4Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 5Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 6Aon Hewitt Provides Tips to Help Workers Prepare for the Upcoming Open Enrollment Season 7Smithsonian scientists discover tropical tree microbiome in Panama 2
... published today in Biology Letters found that ship ... found little evidence that crabs acclimatise to noise over time. ... found that crabs exposed to recordings of ship noise showed ... real world this could have implications for growth and, if ...
... demographics likely put you at risk for salt-sensitive hypertension, ... you. The concept is that free radicals in ... rather than eliminate excess through urination. Excess sodium, in ... hypertension researcher in the Section of Experimental Medicine at ...
... March 2013 issue of The Journal of Urology , ... study conducted by four physicians from Radiotherapy Clinics of ... study, 25 Year Disease Free Survival Rate after Irradiation ... of Recurrence Used for Radical Prostatectomy, is the first-ever ...
Cached Biology News:Ship noise makes crabs get crabby 2Sodium transporter appears likely target for treating salt-sensitive hypertension 2Georgia Physicians' Study Published in The Journal of Urology 2Georgia Physicians' Study Published in The Journal of Urology 3Georgia Physicians' Study Published in The Journal of Urology 4
...
... new Class II safety cabinets Heraeus HERAsafe KS ... user-orientated design. ,The new frameless slanted window ... area. The new front window design makes it ... large work aperture with a height of more ...
... has recently launched a custom synthesis ... (siRNA). Thermos siRNA molecules are: ... 2 DNA bases overhang at the ... Delivered fully deprotected and ready-to-use. ...
Mouse monoclonal [AZ24] to Polo like kinase ( Abpromise for all tested applications)....
Biology Products: